Significance of red cell distribution width measurement for the patients with isolated coronary artery ectasia by Xiao-Lin Li et al.
Li et al. Journal of Translational Medicine 2014, 12:62
http://www.translational-medicine.com/content/12/1/62RESEARCH Open AccessSignificance of red cell distribution width
measurement for the patients with isolated
coronary artery ectasia
Xiao-Lin Li1†, Li-Feng Hong1,2†, Yan-Jun Jia1, Shao-Ping Nie3, Yuan-Lin Guo1, Rui-Xia Xu1, Cheng-Gang Zhu1,
Li-Xin Jiang1 and Jian-Jun Li1*Abstract
Background: Red cell distribution width (RDW) has been recognized as a novel marker for several cardiovascular
diseases. The aim of this study was to evaluate the association between RDW levels and the presence of isolated
coronary artery ectasia (CAE).
Methods: We studied 414 subjects including 113 patients with isolated CAE (Group A), 144 patients with coronary
artery disease (CAD, group B) and 157 angiographically normal controls (group C). Baseline clinical characteristics
and laboratory findings including RDW were compared among three groups.
Results: The levels of RDW were significantly higher in group A and B compared with that in group C (12.97 ± 1.4
and 12.88 ± 1.0 vs 12.34 ± 0.9, p = 0.020) while no difference was found between CAE and CAD (p = 0.17). Additionally,
the levels of CRP were also higher in patients with CAE and CAD compared with normal controls (0.26 ± 0.14 mg/L,
0.31 ± 0.27 mg/L vs 0.20 ± 0.06 mg/L, p = 0.04). The multivariate analysis indicated that RDW and CRP were the
independent variables most strongly associated with the presence of isolated CAE and CAD. There was a positive
correlation between levels of RDW and CRP in patients with isolated CAE (γ=0.532, p = 0.001).
Conclusions: Our data suggested that RDW may be a useful marker and independent predictor for the presence of
isolated CAE.
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Coronary artery ectasia (CAE) is a common finding of
coronary angiography, which is characterized by abnor-
mal coronary dilatation and defined as dilated coronary
artery segments that are greater than 1.5 times the diam-
eter of adjacent normal segment [1,2]. Although previous
studies have demonstrated that CAE could predispose to
adverse coronary events like vasospasm, thrombosis, dis-
section, and even myocardial infarction [3-5], the under-
lying mechanisms for this unique vascular disease are still
unclear.* Correspondence: lijianjun938@yahoo.com
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sion might be a potential cause for the development of
CAE because it was frequently coincident with coronary
artery disease (CAD) in some patients [4,5]. However, a
few observations have also suggested that CAE could be
found in a number of patients independent from the ap-
parent atherosclerotic stenosis, called as the isolated
CAE [4]. Therefore, exploration the potential biomarkers
to discrimination isolated CAE from CAD may be im-
portant for clinical implication.
The red blood cell distribution width (RWD), part of a
routine complete blood count, is a measure of the vari-
ability in the size of circulating erythrocytes and it has
been utilized in the differential diagnosis of anemia [6].
Recently, a lot of previous studies have linked the base-
line RDW to predicting the presence and outcomes of
several cardiovascular diseases including acute coronaryhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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lar disease, stroke, and thrombosis after percutaneous
coronary intervention due to acute myocardial infarc-
tion, cardiac syndrome X, even slow coronary flow syn-
drome [6-14].
Based on the above evidence, we hereby evaluate the
association between RDW levels and the presence of




The study population consisted of 414 patients including
113 patients with isolated CAE (group A) and 144 pa-
tients with CAD (group B) and 157 angiographically
normal controls (group C) who underwent coronary
angiography in our centers between January 2010 and
December 2012 for a variety of indications. The study
population was selected in a consecutive manner. The
protocol was approved by Fu Wai hospital ethics com-
mittee, and complied with the Declaration of Helsinki.
CAE was defined as coronary arteries with a luminal
dilatation of 1.5 fold or more of the adjacent normal cor-
onary segment without significant coronary stenosis in
this study according to previously reported investiga-
tions [1,2]. If there was no adjacent segment, mean di-
ameters of the control patients were used for the related
segment [1]. Patient with CAE but no significant obstruct-
ive coronary artery disease (less than 30% coronary sten-
osis) was defined as the isolated CAE including localized/
focal or diffuse dilatation of a coronary artery [1].
CAD was defined as the left main coronary artery
(LM), the left anterior descending artery (LAD), the left
circumflex coronary artery (LCX), right coronary artery
(RCA) or the main branch of the vascular diameter sten-
osis reaching 50% or more. The patients with signifi-
cantly concomitant CAD (more than 30% stenosis in
any coronary arteries) were excluded. The normal con-
trols were defined as (1) the presence of anginal chest
pain, (2) a normal coronary angiography, and (3) no is-
chemia on myocardial perfusion scintigraphy or during
the treadmill exercise test.
All subjects enrolled in this study had normal hepatic
and renal function. The hyperlipidemia was defined as
low-density lipoprotein cholesterol 160 mg/dl3 and/or
triglyceride (TG) 200 mg/dl3. Patients with history or
evidence of CAD, valvular heart disease, congestive heart
failure, left ventricular dysfunction, echocardiographi-
cally proven left ventricular hypertrophy, a history of
dysphagia, swallowing as well as intestinal motility disor-
ders, untreated thyroid disease, sinus node dysfunction
or conduction disturbance, estrogen replacement ther-
apy, carcinoma, poorly controlled hypertension (systolic
blood pressure >160 mmHg or diastolic blood pressure>105 mmHg), recent major operation (<3 months), auto-
immune disease were also excluded from the study.
In addition, patients who have had previous history of
anemia, have received previous red blood cell transfu-
sion or were on treatment for anemia, such as supple-
mental iron, folate or an erythropoiesis-stimulating
agent were not included in this study. Patients with
known hematological disease such as hemolytic anemia,
neoplastic metastases to the bone marrow, iron replace-
ment therapy that could increase plasma RDW levels
were excluded.
Coronary angiography
Left ventricular and selective coronary angiography for
all enrolled individuals was performed using the stand-
ard Judkin’s techniques, and the results were analyzed by
at least two interventional physicians according to our
previous study [4].
Laboratory examinations
EDTA-anticoagulated peripheral blood sample were taken
from all enrolled patients after 12-hour overnight fast for
the measurement of laboratory parameters. Hemoglobin,
RDW and white blood cell (WBC) counts were deter-
mined by the automated hematology analyzer XE-1200
(Sysmex, Kobe, Japan). The normal range of RDW (%) in
our laboratory was 10-16%. The other biochemical mea-
surements were performed using a molecular analyzer
(Roche Diagnostics, Manheim, Germany).
The plasma was obtained after a centrifugation of
3000 rpm at 4°C for 15 minutes. The levels of high-
sensitivity C-reactive protein (hs-CRP) were determined
using immunoturbidometry (Beckmann Assay 360, Bera,
Calif., USA) as our previously reported [4]. The median
normal value for CRP is 0.8 mg/L, with 90% of normal
values <0.3 mg/L, with a lower detection limit of 0.2 mg/L.
The inter- and intra-assay coefficients of variation were
4.4% and 3.5% respectively.
Statistical analysis
Data were analyzed using SPSS statistical software, ver-
sion 11.5 (SPSS Inc., Chicago, IL, USA). Continuous var-
iables were expressed as mean±SD, and categorical
variables were expressed as percentage. Comparison of
categorical and continuous variables between the groups
was performed using chi-square test and ANOVA test,
respectively.
Because the distribution of hs-CRP was skewed right-
ward, log transformation was made at baseline, and the
significance of any difference in distributions was assessed
by the Wilcoxon rank-sum test as our previously reported
[4]. The univariate and multivariate analysis was used for
baseline clinical characteristics, hs-CRP and RDW. In a
receiver operating characteristic (ROC) curve analysis, an








(n = 113) (n = 144) (n = 157)
WBC (/mm3) 6347±1114 6109±1037 5833±972 0.038
PMC (/mm3) 620±187 553±170 521±107 0.043
Erythrocyte (1012/L) 4.2±0.4 4.3±0.5 4.3±0.3 0.677
HB (g/dl) 12.9±1.3 13.1±1.5 13.6±0.7 0.823
MCV (fL) 83±4.7 85±4.9 83±4.9 0.912
Creatinine (mg/dl) 0.84±0.52 0.88±0.57 0.88±0.93 0.844
hs-CRP (mg/L) 0.26±0.14 0.31±0.27 0.20±0.06 0.042
RDW (%) 12.97±1.4 12.88±1.0 12.34±0.9 0.020
Data are presented as means±SD. CAD = coronary artery disease; WBC = white
blood cell; PMC = peripheral monocyte count; HB = Hemoglobin; Mean
corpuscular volume Hs-CRP = high-sensitivity C-reactive protein; RDW = red
blood cell distribution width.
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the segregation of the presence or absence of CAE. Finally,
association between RDW and hs-CRP was test using




Baseline clinical characteristics of the population studied
with isolated CAE (n = 113), CAD (n = 144) and normal
controls (n = 157) are presented in Table 1. There were
no significant differences among the groups with respect
to body mass index, family history of CAD, function of
left ventricle, and the percentage of lipid profile, dia-
betes. However, compared with group B and group C,
the patients with isolated CAE were younger and were
predominantly male. Additionally, the percentage of
smoking and hypertension was significantly higher in pa-
tients with CAE group compared with control group.
Biomarker for predicting CAE
Laboratory findings from individuals with isolated CAE
and those with CAD and normal controls are summarized
in Table 2. As showed in Table 2, there were no differ-
ences among the groups regarding erythrocyte count,
hemoglobin, mean corpuscular volume, and creatinine









(n = 113) (n = 144) (n = 157)
Age (years) 48±10 57±18 54±13 0.036
Sex (F/M) 97/16 110/34 121/36 0.044
BMI (kg/m2) 24±4 24±3 24±4 0.748
Family history of CAD, n (%) 16 (14) 31 (22) 30 (19) 0.270
Current smoker, n (%) 48 (43) 32 (22) 15 (10) 0.041
Hypertension, n (%) 34 (31) 39 (27) 31 (20) 0.035
Hyperlipidemia, n (%) 31 (27) 40 (28) 53 (34) 0.509
Diabetes, n (%) 13 (12) 22 (15) 20 (13) 0.713
LVEF (%) 58±6 61±8 60±7 0.824
Medications on admission
Aspirin, n (%) 52 (46) 60 (42) 58 (37) 0.192
β-blocke, n (%) 25 (22) 30 (21) 29 (19) 0.307
ACEI/ARB, n (%) 22 (20) 33 (23) 27 (17) 0.316
Statin, n (%) 17 (15) 22 (16) 19 (12) 0.818
CCB, n (%) 9 (8) 14 (10) 14 (9) 0.934
Data are presented as frequencies (percentages) for categorical variables and
means±SD. CAE = coronary artery ectasia; CAD = coronary artery disease; BMI =
body mass index; CAD = family history of CAD; LVEF = left ventricular ejection
fraction; ACEI/ARB = angiotensin-converting enzyme inhibito/angiotensin
receptor blocker; CCB = calcium channel blocker.higher in group A and B compared with that in group C
(12.97 ± 1.4 and 12.88 ± 1.0 vs 12.34 ± 0.9, p = 0.020) while
no difference was found between CAE and CAD (12.97 ±
2.4 vs.12.88 ± 2.0, p = 0.17). In addition, the levels of CRP
were also higher in patients with CAE and CAD com-
pared with normal controls (0.26 ± 0.14 mg/L, 0.31 ±
0.27 mg/L vs 0.20 ± 0.06 mg/L, p = 0.04). Moreover, The
data also showed an increased numbers of white blood
cells in patients with isolated CAE and CAD group com-
pared with normal controls (6347±1114/mm3 and 6109±
1037/mm3 vs 5833±972/mm3, p = 0.038). Similarly, the
peripheral circulating monocyte cells were significantly
higher in patients with CAE group compared with CAD
and normal controls (620±187/mm3 vs 553±170/mm3 and
521±107/mm3, p = 0.043).
Independent risks for predicting CAE by multivariate
analysis
Al total of 7 variables associated with isolated CAE in-
cluding age, sex, smoking, peripheral circulating white
blood cell, moncyte cell, hs-CRP and RDW with p < 0.05
in univariate analysis are presented in Table 3. And then,
we put those 7 variables into the multivariate analysis.
Interestingly, we found that sex, smoking, hs-CRP and
RDW were the independent variables most strongly as-
sociated with isolated CAE (sex: odds ratio 1.13, 95%
confidence interval 1.13 to 2.25, p = 0.006; smoking: odds
ratio 1.22, 95% confidence interval 1.08 to 2.48, p = 0.000;
hs-CRP: odds ratio 1.15, 95% confidence interval 1.04 to
2.03, p = 0.031; RDW: odds ratio 1.38, 95% confidence
interval 1.11 to 2.97, p = 0.003; Table 3).
ROC analysis
Finally, in a ROC curve analysis with area under curve
(AUC) = 0.63, 95% CI: 0.56–0.70, we found that an RDW
value of 12.73% was used as an effective cut-point in the
segregation of the presence or absence of isolated CAE,







OR 95% CI OR 95% CI
Age 1.04 1.01-1.07 0.017 0.94 0.63-1.37 0.331
Sex 1.15 1.04-1.19 0.004 1.13 1.13-1.25 0.006
Smoking 1.10 1.05-1.72 <0.001 1.22 1.08-2.48 0.000
WBC 1.02 1.05-1.47 0.042 1.05 0.39-1.17 0.608
PMC 1.07 1.00-155 0.050 0.87 0.57-1.35 0.219
Hs-CRP 1.13 1.08-2.38 0.005 1.15 1.04-2.03 0.031
RDW 1.38 1.12-2.07 0.002 1.38 1.11-1.97 0.003
CAE = coronary artery ectasia; OR = odds ratio; CI = confidence interval; WBC =
white blood count; PMC = peripheral monocyte count; hs-CRP = high-sensitivity
C-reactive protein; RDW = red blood cell distribution width.
Li et al. Journal of Translational Medicine 2014, 12:62 Page 4 of 6
http://www.translational-medicine.com/content/12/1/62a sensitivity of 57.7% and a specificity of 66.2% were ob-
tained (Figure 1).
Correlations of RDW with hs-CRP in patients with CAE
We also examined the correlation between the levels of
RDW and hs-CRP in patients with CAE (n = 113). As
shown in Figure 2, there was marked positive correlation
between levels of RDW and hs-CRP in patients with iso-
lated CAE (γ=0.532, p = 0.001).
Discussion
The major findings of the present study are that (1) the
RDW levels were significantly higher in patients with
isolated CAE and CAD than that in angiographically
normal controls; (2) the baseline RDW level was an in-
dependent predictor for the presence of isolated CAE;Figure 1 Receiver operating characteristic curve of red blood cell dist
coronary artery ectasia (CAE) in studied patients (n = 113).(3) there was a positive correlation between levels of
RDW and CRP in patients with isolated CAE. These
data, therefore, provided additional information regard-
ing the association of RDW with isolated CAE in the
cardiovascular field.
Although the clinical significance of isolated CAE is
not fully understood, it has been demonstrated to be not
a benign disorder and associated with a high risk of cor-
onary events. Until now, the clinical studies on this
unique inappropriate dilation of coronary arteries are
relatively limited. Previous small sample studies sug-
gested that CAE appeared to be associated with smoking
and more male individuals [1,3,5]. Moreover, CAE has
also been reported to be associated with atherosclerotic
vascular disease, heterozygous familial hypercholesterol-
emia, usage of substances inhibitors including herbicide
spray, acetylcholinesterase inhibitors and nitrate, prior
arterial balloon angioplasty, polyarteritis nodosa and
Kawasaki syndrome [1-5]. Therefore, the exploration of
factors contributing to the development of isolated CAE
or predictor biomarkers of isolated CAE may be of a
great interesting.
RDW is a numerical measure of the variability in size
of circulating erythrocytes. Generally, it is used, in com-
bination with mean corpuscle volume, as an indicator of
differential diagnosis of anemia [6]. Factors that contrib-
ute to increased erythrocyte size heterogeneity include
iron or vitamin B12/folate deficiency, decreased erythro-
cyte life-span, impaired erythropoiesis and factors that
contribute to erythrocyte fragmentation including in-
creased fragility and destruction of red cell [6]. Recently,
RDW has been shown to be a strong predictor for theribution width (RDW) for predicting the presence of isolated
γFigure 2 Correlation analysis of plasma CRP levels and RDW in patients with isolated CAE. There were marked positive correlation between
the plasma levels of CRP and RDW (n = 113, γ=0.532, p = 0.001).
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verse outcomes in multiple settings [15]. Although those
studies demonstrated the role of RDW in a variety of
cardiovascular disease, the role of RDW in CAE, espe-
cially in association between RDW and isolated CAE are
lacking. A recent small size study performed by Dogdu
et al. [16] in 54 patients with CAE and 40 normal indi-
viduals reported that RDW were higher in the CAE pa-
tients compared with the control subjects. However,
whether RDW is an independent predictor for patients
with CAE was clearly not evaluated. Moreover, the po-
tential mechanism was not also examined. In the present
study we extended previous studies and for the first time
found that baseline RDW levels is an independent pre-
dictor for patients with isolated CAE using univariate
and multivariate logistic regression analysis.
The pathophysiologic mechanisms that the correlation
of higher levels of RDW with CAE are largely unknown.
It has been hypothesized that the systemic factors, such
as inflammation and oxidative stress, might be the po-
tential contributions. Previous studies suggested that
higher RDW was associated with inflammatory markers
such as soluble tumor necrosis factor receptors and CRP
in the setting of atherosclerosis and other chronic dis-
eases [17-19]. A strong association between RDW and
inflammatory markers was also found in a large cohort
of unselected adult outpatients, as well as patients with
inflammatory bowel disease [20]. Pro-inflammatory cyto-
kines may contribute to an increased RDW through en-
hanced oxidative stress [17]. Red blood cells have huge
antioxidant capacity and serve as a primary oxidative
sink, but they are prone to oxidative damage, which re-
duces cell survival and induces the release of juvenile
erythrocytes into circulation [20,21]. Inflammation may
also contributes to an increased RDW by impairing iron
metabolism, inhibiting the production of or response toerythropoietin, and shortening red blood cell survival
[22,23]. Additionally, inflammatory cytokines have been
found to inhibit erythropoietin-induced erythrocyte
maturation and induce the release of juvenile erythro-
cytes into circulation which lead to an increased RDW
[24-26]. Interestingly, we have previously proposed that
the inflammation may play a pathogenic role in isolated
CAE [2]. This hypothesis has also been demonstrated by
our clinical observations in patients with isolated CAE
[4]. In the present study, the data further demonstrated
a positive correlation between RDW and plasma CRP,
suggesting an inflammatory mechanism may be involved
in higher RDW levels in patients with CAE.
In conclusion, in the present study, our data demon-
strated that RDW levels were higher, an independent
predicting for isolated CAE, and positive correlated with
inflammatory marker, CRP in patients with isolated
CAE, suggesting that RDW, an easy, inexpensive, rou-
tinely reported test, whose assessment might allow the
acquisition of significant diagnostic and prognosis infor-
mation in patients with cardiovascular disorders [15]
may be a useful marker and independent predictor for
patients with isolated CAE. Further investigation is
worthy of exploring the prognostic role of RDW in pa-
tients with isolated CAE.
Study limitations
Although the association the increased RDW with the
presence of isolated CAE has been established in the
present study, whether RDW has a causal role contribut-
ing to isolated CAE or a marker of the disease process
needs further investigation. Additionally, relative small
sample size may limit the significance of the present
study. Moreover, angiography cannot assess plaque bur-
den, patients without evidence of luminal stenosis by
angiography may also have plaque burden in the wall of
Li et al. Journal of Translational Medicine 2014, 12:62 Page 6 of 6
http://www.translational-medicine.com/content/12/1/62the coronary arteries. It would be better to examine with
intravascular techniques such as ultrasound whether the
patients with isolated CAE had evidence of atheroscler-
otic plaque. Moreover, the relation of RDW level to the
severity of isolated CAE or anatomical characteristics
was not evaluated. The fact that the levels of folate, iron,
and vitamin B12 were not evaluated was another limita-
tion. Finally, the prognostic role of RDW in patients
with isolated CAE needs to be investigated.
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